New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
May 5, 2020 - Rhodes Pharmaceuticals launched an authorized brand alternative of its (Rhodes) branded Aptensio XR (methylphenidate) extended-release capsules.
Download PDF
Return to publications
